An Easy, Accurate, and Affordable Blood Test for Early Colorectal Cancer Detection


Beacon Biomedical's laboratory developed test (LDT) solutions help primary care providers screen their patients for the presence of undiagnosed cancer to improve their chances of survivability. Our newest test, BeScreened-CRC, offers a simple blood-based solution to patients who are unwilling or unable to use traditional colorectal cancer screening methods. 


Are you at risk for colorectal cancer?

Colorectal cancer (CRC) is the third deadliest cancer in the US, even though it can be effectively treated when diagnosed during its early stages. But in order to detect CRC earlier, men and women over the age of 50 must get screened. Unfortunately, more than one third of the screening-eligible population choose not to get screened, and unscreened patients make up nearly 67% of all CRC-related deaths.

If you’re one of these individuals who have avoided CRC screening because your uncomfortable with or inconvenienced by current testing methods, then BeScreened™–CRC may be a great option for you.

CRC Risk Image V2.png

Providing the right test at the right time to the patients who need it most.

The world’s best cancer experts, decades of research, and extensive data all tell us the same thing: early detection saves lives. That’s why Beacon Biomedical’s top priority is to develop simple, blood-based cancer screening tests that patients feel comfortable using. We believe that a future without cancer begins with finding and treating today’s early-stage cancer patients before the disease becomes too difficult to control.


For Patients & Caregivers

Learn more about the importance of screening for colorectal cancer, and how BeScreened™-CRC is different from colonoscopies and fecal-based tests.

For Providers

Learn the facts about BeScreened™-CRC and find out how this blood-based test can help your patients comply with colorectal cancer screening.